Condensed tricycline-dependent kinase inhibitors, methods of preparation, and pharmaceuticals containing these compounds

VN10059290BActive Publication Date: 2026-07-15JIANGSU HENGRUI MEDICINE CO LTD

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: VN1202305369
Authority / Receiving Office: VN · VN
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-01-28
Publication Date: 2026-07-15
Estimated Expiration: 2042-01-28

Application Information

Patent Timeline

28 Jan 2022

Application

VN1202305369

15 Jul 2026

Publication

VN10059290B

Inventors: LI, Yunfei; LIU, Haomiao

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This section refers to condensed tricyclic cyclin-dependent kinase inhibitors and their preparation methods and pharmaceutical formulations. Specifically, the structure of the dependent kinase inhibitor is shown in formula I, in which the pharmaceutical substituents are described in the table. Condensed tricyclic cyclin-dependent kinase inhibitors are used to prevent and / or treat diseases related to cyclin-dependent kinases, specifically cancers.

Need to check novelty before this filing date? Find Prior Art